Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts
A bank of 59 well-characterised prostate cancer patient-derived xenografts was established, including 17 classed as research-ready covering the disease-spectrum which, plus associated resources (organoids, serum, DNA/RNA profiles, tissue), are available for collaborative projects. This eagerly-antic...
Guardado en:
Autor principal: | Charlotte L. Bevan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/feb3485b07fb4d0dbd2023b9e45716e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
por: Gail P. Risbridger, et al.
Publicado: (2021) -
Patient-derived xenografts and organoids model therapy response in prostate cancer
por: Sofia Karkampouna, et al.
Publicado: (2021) -
Breaking Down the LMS Walls
por: Michael Hotrum
Publicado: (2005) -
Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
por: Massimo Moro, et al.
Publicado: (2017) -
Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
por: Miguel Martin, et al.
Publicado: (2021)